Abstract
Protein serine/threonine phosphatase 2A (PP2A) activity must be tightly controlled to maintain cell homeostasis. Here, we report the identification of a previously uncharacterized mammalian protein, type 2A-interacting protein (TIP), as a novel regulatory protein of PP2A and the PP2A-like enzymes PP4 and PP6. TIP is a ubiquitously expressed protein and parallels the distribution of the PP2A catalytic subunit. Unlike its role in yeast, TIP does not interact with the mammalian homolog of type 2A-associated protein of 42 kDa (Tap42), α4, but instead associates with PP2A, PP4 and PP6 catalytic subunits independently of mammalian target of rapamycin kinase activity. Interestingly, the 20 kDa TIP splice variant TIP_i2, which lacks amino acids 173–272 of TIP's C-terminus, does not interact with PP2A; this finding indicates that residues 173–272 are important for the assembly of the TIP·phosphatase complex. In contrast to purified PP2A holoenzymes, TIP·PP2A complexes are devoid of phosphatase activity. Furthermore, alterations in the cellular levels of TIP influence the phosphorylation state of a specific protein substrate of ataxia-telangiectasia mutated (ATM)/ATM- and Rad3-related (ATR) kinases. Elevated levels of TIP result in an increase in the phosphorylation state of this protein substrate, whereas TIP-depleted cells exhibit a significant decrease in this protein's phosphorylation state, which is reversed by treatment with the PP2A inhibitor okadaic acid. These results indicate TIP is a novel inhibitory regulator of PP2A and implicate a role for TIP·PP2A complexes within the ATM/ATR signaling pathway controlling DNA replication and repair.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- PP2A:
-
protein serine/threonine phosphatase 2A
- PP4:
-
protein serine/threonine phosphatase 4
- PP6:
-
protein serine/threonine phosphatase 6
- PP1:
-
protein serine/threonine phosphatase 1
- TIP:
-
type 2A-interacting protein
- TIP_i2:
-
20 kDa splice variant of TIP
- Tap42:
-
type 2A-associated protein of 42 kDa
- mTOR:
-
mammalian target of rapamycin
- ATM:
-
ataxia-telangiectasia mutated
- ATR:
-
ATM- and Rad3-related
References
Abraham RT . (2001). Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15: 2177–2196.
Adams DG, Coffee Jr RL, Zhang H, Pelech S, Strack S, Wadzinski BE . (2005). Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. J Biol Chem 280: 42644–42654.
Beck T, Hall MN . (1999). The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature 402: 689–692.
Bryant JC, Westphal RS, Wadzinski BE . (1999). Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Bα subunit. Biochem J 339 (Part 2): 241–246.
Cayla X, Goris J, Hermann J, Hendrix P, Ozon R, Merlevede W . (1990). Isolation and characterization of a tyrosyl phosphatase activator from rabbit skeletal muscle and Xenopus laevis oocytes. Biochemistry 29: 658–667.
Chen J, Martin BL, Brautigan DL . (1992). Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257: 1261–1264.
Chen J, Peterson RT, Schreiber SL . (1998). α4 associates with protein phosphatases 2A, 4, and 6. Biochem Biophys Res Commun 247: 827–832.
Di Como CJ, Arndt KT . (1996). Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev 10: 1904–1916.
Dozier C, Bonyadi M, Baricault L, Tonasso L, Darbon JM . (2004). Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B′ regulatory subunit. Biol Cell 96: 509–517.
Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A et al. (2002). Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415: 141–147.
Gingras AC, Caballero M, Zarske M, Sanchez A, Hazbun TR, Fields S et al. (2005). A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol Cell Proteomics 4: 1725–1740.
Goodarzi AA, Jonnalagadda JC, Douglas P, Young D, Ye R, Moorhead GB et al. (2004). Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J 23: 4451–4461.
Inui S, Sanjo H, Maeda K, Yamamoto H, Miyamoto E, Sakaguchi N . (1998). Ig receptor binding protein 1 (α4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 92: 539–546.
Jacinto E, Guo B, Arndt KT, Schmelzle T, Hall MN . (2001). TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol Cell 8: 1017–1026.
Janssens V, Goris J . (2001). Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353: 417–439.
Jiang Y, Broach JR . (1999). Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast. EMBO J 18: 2782–2792.
Kloeker S, Reed R, McConnell JL, Chang D, Tran K, Westphal RS et al. (2003). Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with α4 protein. Protein Expr Purif 31: 19–33.
Kloeker S, Wadzinski BE . (1999). Purification and identification of a novel subunit of protein serine/threonine phosphatase 4. J Biol Chem 274: 5339–5347.
Li M, Guo H, Damuni Z . (1995). Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 34: 1988–1996.
Luke MM, Della Seta F, Di Como CJ, Sugimoto H, Kobayashi R, Arndt KT . (1996). The SAP, a new family of proteins, associate and function positively with the SIT4 phosphatase. Mol Cell Biol 16: 2744–2755.
McCright B, Rivers AM, Audlin S, Virshup DM . (1996). The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem 271: 22081–22089.
Murata K, Wu J, Brautigan DL . (1997). B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc Natl Acad Sci USA 94: 10624–10629.
Nanahoshi M, Nishiuma T, Tsujishita Y, Hara K, Inui S, Sakaguchi N et al. (1998). Regulation of protein phosphatase 2A catalytic activity by α4 protein and its yeast homolog Tap42. Biochem Biophys Res Commun 251: 520–526.
Petersen P, Chou DM, You Z, Hunter T, Walter JC, Walter G . (2006). Protein phosphatase 2A antagonizes ATM and ATR in a Cdk2- and Cdc7-independent DNA damage checkpoint. Mol Cell Biol 26: 1997–2011.
Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM et al. (1999). Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 59: 4375–4382.
Scheidtmann KH, Mumby MC, Rundell K, Walter G . (1991). Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol Cell Biol 11: 1996–2003.
Schmidt A, Beck T, Koller A, Kunz J, Hall MN . (1998). The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease. EMBO J 17: 6924–6931.
Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC . (1996). Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17: 1201–1207.
Strack S, Zaucha JA, Ebner FF, Colbran RJ, Wadzinski BE . (1998). Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits. J Comp Neurol 392: 515–527.
Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, Ropers HH et al. (2001). MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet 29: 287–294.
Van Hoof C, Martens E, Longin S, Jordens J, Stevens I, Janssens V et al. (2005). Specific interactions of PP2A and PP2A-like phosphatases with the yeast PTPA homologues, Ypa1 and Ypa2. Biochem J 386: 93–102.
Wada T, Miyata T, Inagi R, Nangaku M, Wagatsuma M, Suzuki D et al. (2001). Cloning and characterization of a novel subunit of protein serine/threonine phosphatase 4 from mesangial cells. J Am Soc Nephrol 12: 2601–2608.
Walsh AH, Cheng A, Honkanen RE . (1997). Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Lett 416: 230–234.
Acknowledgements
We thank Dr Joy Marlo and Matthew Mazalouskas for expert technical assistance and analysis. We are grateful to Dr Roger Colbran, Dr David Cortez and our laboratory colleagues for helpful discussions. This work was supported by grants from the National Institutes of Health (GM51366 and DK070787 to BEW), the Vanderbilt Diabetes Research & Training Center (DK20593), the Vanderbilt-Ingram Cancer Center (CA68485) and the Center for Molecular Neuroscience (MH19732).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
McConnell, J., Gomez, R., McCorvey, L. et al. Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway. Oncogene 26, 6021–6030 (2007). https://doi.org/10.1038/sj.onc.1210406
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210406
Keywords
This article is cited by
-
TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer
Cellular Oncology (2023)
-
TIPRL potentiates survival of lung cancer by inducing autophagy through the eIF2α-ATF4 pathway
Cell Death & Disease (2019)
-
To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling
Cellular and Molecular Life Sciences (2019)
-
Genetic association and meta-analysis of a schizophrenia GWAS variant rs10489202 in East Asian populations
Translational Psychiatry (2018)
-
cAMP signaling increases histone deacetylase 8 expression via the Epac2–Rap1A–Akt pathway in H1299 lung cancer cells
Experimental & Molecular Medicine (2017)